Ledger.Open graph →
SEC Form D · filed January 15, 2025

Araceli Biosciences Inc

Offering
$8.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
TIGARD, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kevin Gabelein · Tigard, ORDirectorSean O'Neill · Tirgard, ORDirectorKirk Malloy · Tigard, ORDirectorWilliam Cortelyou · Tigard, ORDirectorBruce Rhine · Tigard, ORDirectorJ. William Freytag · Tigard, ORDirectorSamraat Raha · Tigard, ORDirectorShawn Macdonald · Tigard, ORExecMatt Beaudet · Tigard, ORExec · DirectorKirk Malloy · Tigard, ORDirectorJ. William Freytag · Tigard, ORDirectorMatt Beaudet · Tigard, ORExec · DirectorShawn Macdonald · Tigard, ORExecSamraat Raha · Tigard, ORDirectorBruce Rhine · Tigard, ORDirectorSean O'Neill · Tirgard, ORDirectorKevin Gabelein · Tigard, ORDirectorWilliam Cortelyou · Tigard, ORDirectorNakul Mandan · San Francisco, CADirectorPaul Daversa · WESTPORT, CTDirectorEd Bachtold · BELLEVUE, WADirectorScott Rerucha · BELLEVUE, WADirectorJarrett Johnson · BELLEVUE, WADirectorBrent Eley · BELLEVUE, WAExecChris Steward · BELLEVUE, WAExec · DirectorChris Gurdjian · BELLEVUE, WADirectorShakti C'Ganti · Southlake, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗